Oculis
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Founded Year
2017Stage
Series C | AliveTotal Raised
$93.42MLast Raised
$57M | 1 yr agoAbout Oculis
Oculis is a Lausanne, Switzerland-based clinical-stage biopharmaceutical company developing topical ophthalmic treatments for ophthalmic diseases for both back- and front-of-the-eye in order to improve the sight and lives of patients worldwide.
Oculis Headquarter Location
EPFL Innovation Park Building D
Lausanne, 1015,
Switzerland
+41 21 711 3970
Expert Collections containing Oculis
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Oculis is included in 2 Expert Collections, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Diabetes
1,750 items
Oculis Patents
Oculis has filed 6 patents.
The 3 most popular patent topics include:
- Dosage forms
- Drug delivery devices
- Pharmaceutical industry
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/29/2017 | 10/5/2021 | Drug delivery devices, Dosage forms, Pharmacokinetics, Diseases of the eye and adnexa, Ophthalmology | Grant |
Application Date | 11/29/2017 |
|---|---|
Grant Date | 10/5/2021 |
Title | |
Related Topics | Drug delivery devices, Dosage forms, Pharmacokinetics, Diseases of the eye and adnexa, Ophthalmology |
Status | Grant |
Latest Oculis News
Jun 29, 2022
Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment...
Oculis Web Traffic
Oculis Rank
When was Oculis founded?
Oculis was founded in 2017.
Where is Oculis's headquarters?
Oculis's headquarters is located at EPFL Innovation Park, Lausanne.
What is Oculis's latest funding round?
Oculis's latest funding round is Series C.
How much did Oculis raise?
Oculis raised a total of $93.42M.
Who are the investors of Oculis?
Investors of Oculis include Silfurberg, Brunnur Ventures, Bay City Capital, Novartis Venture Funds, Pivotal bioVenture Partners and 11 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.